Showing 4381-4390 of 8791 results for "".
IOL Exchange: Principle and Practice Rates
https://crstoday.com/crst-issues/2002-may/0502_051-html/40163/A look at the common complications leading to foldable IOL explantation and the factors surgeons should consider before, during, and after the procedure.Malpractice Litigation and Refractive Surgery Complications
https://crstoday.com/crst-issues/2002-jul/crst0702_11-php/40136/How do you release legal risks?Choosing the Proper IOL After LASIK
https://crstoday.com/crst-issues/2001-nov/1_1101_01-html/40011/Here are three techniques to help you manage this difficult postrefractive surgery situation.AI Beyond the Clinic
https://crstoday.com/crst-issues/jan-2026/ai-beyond-the-clinic/54538/How regulation and reimbursement are accelerating AI and home monitoring.Tracking Premium IOL Satisfaction Has Hidden Perks
https://crstoday.com/crst-issues/2018-jan/tracking-premium-iol-satisfaction-has-hidden-perks/43567/A system that gathers outcomes data and keeps in touch with patients also brings reimbursement and referral benefits.Exploring the formulation of CEQUA
https://crstoday.com/crst-supplements/exploring-the-formulation-of-cequa/exploring-the-formulation-of-cequa/45214/What could CEQUA provide for patients inadequately controlled on Restasis®?Spherical Aberration: The Next Frontier
https://crstoday.com/crst-issues/2006-nov/crst1106_18-php/40923/Only understanding the math can ophthalmologists target the ideal correction for their patients.From Artificial to Assisted Intelligence
https://crstoday.com/crst-issues/nov-dec-2024/from-artificial-to-assisted-intelligence/45407/Rethinking AI in keratoconus diagnosis and management.Streamlining Cataract Planning
https://crstoday.com/crst-issues/sept-2025/streamlining-cataract-planning/45560/Consolidating diagnostics, eliminating reentry, and enabling real-time OR edits.Premium IOL Channel Growth
https://crstoday.com/crst-issues/mar-2023/premium-iol-channel-growth/44960/Stop dabbling and dare to differentiate with presbyopia-correcting IOL offerings.